Molecular Immunoengineering

Track Chair(s)

• 

  Elizabeth Wayne, PhD (she/her/hers)

  Assistant Professor
  Carnegie Mellon University, United States
• JW

  John Wilson, Ph.D.

  Associate Professor
  Vanderbilt University
  Nashville, Tennessee, United States
• KM

  Kathryn Miller-Jensen

  Associate Professor
  Yale University, United States

Moderator(s)

• HA

  Handan Acar

  Assistant Professor
  University of Oklahoma Stephenson School of Biomedical Engineering, United States
• 

  Aaron Morris, PhD

  Assistant Professor
  University of Michigan
  Ann Arbor, Michigan, United States

Presentations:

• 3:00 PM – 3:15 PM PDT

  Vaccine-mediated co-engagement of CAR T and endogenous T-cells eradicates tumors with pre-existing antigenic heterogeneity
  

  Presenting Author: Leyuan Ma, PhD – University of Pennsylvania

  Co-Author: alexander Hostetler – MIT

  Co-Author: Duncan Morgan – MIT

  Co-Author: Laura Maiorino – MIT

  Co-Author: J. Christopher Love – MIT

  Primary Investigator: Darrell Irvine – MIT
• 3:15 PM – 3:30 PM PDT

  Development and Validation of Recombinant Fusions of Efferocytic Mediators with Antigen for Antigen-Specific Immunomodulation
  

  Presenting Author: Joseph W. Reda, BS (they/them/theirs) – University of Chicago

  Co-Author: Andrew Tremain (he/him/his) – Kyverna Therapeutics

  Co-Author: Suzana Gomes (she/her/hers) – University of Chicago

  Co-Author: Yue Wang (she/her/hers) – University of Chicago

  Primary Investigator: Jeffrey Hubbell – University of Chicago
• 3:30 PM – 3:45 PM PDT

  Antibody-Dependent Phagocytosis by SIRPα-Knockout Macrophages for Cancer Immunotherapy
  

  Presenting Author: Tristan Marchena – University of Pennsylvania

  Co-Author: Lawrence J. Dooling, PhD (he/him/his) – University of Pennsylvania

  Co-Author: Jason C. Andrechak – University of Pennsylvana

  Primary Investigator: Dennis E. Discher, PhD (he/him/his) – University of Pennsylvania
• 3:45 PM – 4:00 PM PDT

  Programming Immunity with Nanoscale Architecture
  

  Presenting Author: Michelle Teplensky, PhD (she/her/hers) – Boston University
• 4:00 PM – 4:15 PM PDT

  Antibody-lectin chimeras for glyco-immune checkpoint blockade
  

  Presenting Author: Jessica Stark (she/her/hers) – Stanford University
• 4:15 PM – 4:30 PM PDT

  Sensitizing solid tumors to immunotherapy by bispecific nano conjugate
  

  Presenting Author: Yifan wang, PhD – University of Texas MD Anderson Cancer Center

  Co-Author: Daeyong Lee – MD Anderson Cancer Center

  Co-Author: Kristin Huntoon – MD Anderson Cancer Center

  Co-Author: Shiyan Dong – University of Texas MD Anderson Cancer Center

  Co-Author: Betty Y. S. Kim – The University of Texas MD Anderson Cancer Center

  Primary Investigator: Wen Jiang – University of Texas MD Anderson Cancer Center